2020
DOI: 10.31857/s0869813920100027
|View full text |Cite
|
Sign up to set email alerts
|

Оценка Эффективности Превентивной Терапии С Индуктором Шаперонов U133 В Модели Доклинической Стадии Болезни Паркинсона У Пожилых Крыс

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Recently, therapy based on U-133 administration was applied in a model of the preclinical stage of PD in elderly rats. It was shown that U-133 weakened the process of neurodegeneration in the substantia nigra pars compacta and counteracted the development of neuroinflammation, decreased the amount of aggregated α-synuclein and regression of post-translationally modified α-synuclein, eliminated anhedonia, and prevented the development of neurodegeneration in monoaminergic emetogenic structures of the brain in experimental PD [13,15]. Therefore, the study of the neuroprotective effects of 1,4-naphthoquinones in general and their antiparkinsonian activity in particular may have good prospects.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, therapy based on U-133 administration was applied in a model of the preclinical stage of PD in elderly rats. It was shown that U-133 weakened the process of neurodegeneration in the substantia nigra pars compacta and counteracted the development of neuroinflammation, decreased the amount of aggregated α-synuclein and regression of post-translationally modified α-synuclein, eliminated anhedonia, and prevented the development of neurodegeneration in monoaminergic emetogenic structures of the brain in experimental PD [13,15]. Therefore, the study of the neuroprotective effects of 1,4-naphthoquinones in general and their antiparkinsonian activity in particular may have good prospects.…”
Section: Discussionmentioning
confidence: 99%
“…Their role in protecting against neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease has also been established [4][5][6][7][8][9][10][11][12]. One of the 1,4-NQs synthesized by our group, U-133, exhibited a promising neuroprotective effect in an in vivo PD rat model [13].…”
Section: Introductionmentioning
confidence: 95%